Records containing: Progressive Supranuclear Palsy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-08-2818F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-08-11A 6 Month, Open-Label, Pilot Futility Clinical Trial of Monthly Young Healthy Male Donor Plasma Transfusions for Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2020-02-17Phase 1 Test-retest Evaluation of [18F]MNI-958 PET as an Imaging Marker for Tau Protein in the Brain of Patients With Alzheimer's Disease and Probable PSP as Compared to Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-02-05A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Tolfenamic Acid for the Treatment of Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2020-01-23tDCS Plus Physical Therapy for Progressive Supranuclear Palsy: a Double Blind Randomized Sham-controlled Study With Wearing Sensors Technology
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-01-22Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear Palsy: a Double Blind Cross-over Sham-controlled Study Using Wearing Sensors Technology
-
CLINICAL_TRIALS study record update · 2020-01-10Mono-center, Prospective, Double-blind, Placebo-controlled, Randomized Clinical Phase IIa Trial to Assess the Safety, Tolerability, and Immediate Biological Effects of Coenzyme Q10 - nanoQuinon® in Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2019-10-21Phase 0 Evaluation of Clinical and Neuroimage (18F-PM-PBB3 PET) Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal Controls
-
CLINICAL_TRIALS study record update · 2019-09-20Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2019-09-13Postural Instability in Progressive Supranuclear Palsy: Why do Patients With PSP Fall?
-
CLINICAL_TRIALS study record update · 2019-08-01Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
-
CLINICAL_TRIALS study record update · 2019-07-18Biomarkers in Neural Disorders
-
CLINICAL_TRIALS study record update · 2019-04-05A 12 Week Randomized, Double Blind, Placebo-Controlled Pilot Study of Davunetide (NAP, AL-108) in Predicted Tauopathies
-
CLINICAL_TRIALS study record update · 2019-03-25Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Probable Alzheimer's Disease or Progressive Supranuclear Palsy Compared With Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2018-09-04A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2018-06-15Effects of Coenzyme Q10 in PSP and CBD, A Randomized, Placebo-Controlled, Double Blind Cross Over Pilot Study
-
CLINICAL_TRIALS study record update · 2018-03-27The Role of the Neuropsychological Evaluation for Early Diagnosis of Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2017-10-06Phase 0 Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Progressive Supranuclear Palsy or Alzheimer's Disease Compared to Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2017-07-26A Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy
-
CLINICAL_TRIALS study record update · 2017-04-12An Open-label Trial of Alpha-lipoic Acid/L-acetyl Carnitine for Progressive Supranuclear Palsy (PSP): Effect Upon Oxidative Damage and Mitochondrial Biomarkers
-
CLINICAL_TRIALS study record update · 2017-04-10Genetic and Environmental Risk Factors for PSP
-
CLINICAL_TRIALS study record update · 2017-04-10Energy Metabolism in Neurodegenerative Diseases: A Randomized, Double Blind, Placebo-Controlled Clinical Pilot Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.
-
CLINICAL_TRIALS study record update · 2017-03-31Contribution of Magnetic Resonance Imaging (Diffusion Tensor Imaging and Magnetic Susceptibility Imaging and Resting Activation Imaging) in the Diagnosis of Parkinsonian Syndromes in Elderly Subjects.
-
CLINICAL_TRIALS study record update · 2016-12-06Rehabilitation in Patients With Progressive Supranuclear Palsy: Effectiveness of Two Intensive Protocols
-
CLINICAL_TRIALS study record update · 2016-02-04Pilot, Exploratory Study With [F18]-FDDNP-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism